| 000 | 00732cam a2200241 4500 | ||
|---|---|---|---|
| 001 | A020941 | ||
| 008 | 090401t2002 xxu||||| |||| 00| 0 eng d | ||
| 020 | _a1842571583 | ||
| 035 | _a(Sirsi) i9781842571583 | ||
| 060 | _aWE 346. | ||
| 110 | _aNice | ||
| 245 | _aGuidance on the use of etanercept and infliximab for the treatment of rheumatoid arthritis. National Institute for Clinical Excellence. 2002. | ||
| 260 |
_bNICE, _c2002 |
||
| 300 | _a22p | ||
| 500 | _aTechnology Appraisal Guidance No. 36. | ||
| 591 | _aP | ||
| 650 | _aArthritis, rheumatoid | ||
| 650 | _aDrug therapy | ||
| 650 | _aClinical effectiveness | ||
| 650 | _aEvidence based practice | ||
| 710 | _aNational Inst Clinical Excellence | ||
| 942 | _n0 | ||
| 999 |
_c11039 _d11039 |
||